10.12.2012 Views

HIV/AIDS Treatment and Care : Clinical protocols for the European ...

HIV/AIDS Treatment and Care : Clinical protocols for the European ...

HIV/AIDS Treatment and Care : Clinical protocols for the European ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>HIV</strong>/<strong>AIDS</strong> TREATMENT AND CARE FOR INJECTING DRUG USERS<br />

• <strong>Care</strong>ful monitoring of IDUs on ARVs <strong>and</strong> continuing pain medication is required, as dose adjustments<br />

or a change of timing may be necessary.<br />

• Clinicians should treat IDUs on methadone <strong>for</strong> pain <strong>the</strong> same way <strong>the</strong>y do non-methadone patients.<br />

26<br />

4.6.2. Pain management in patients receiving buprenorphine<br />

Fur<strong>the</strong>r clinical studies are needed of patients treated <strong>for</strong> pain while on buprenorphine. Like methadone,<br />

buprenorphine has strong analgesic properties; however, <strong>the</strong> once-daily dosage <strong>for</strong> treatment<br />

of substance use is not sufficient to sustain pain relief. There<strong>for</strong>e:<br />

• Patients on buprenorphine needing pain relief should first be treated with a non-opioid analgesic<br />

when appropriate; a temporary increase in buprenorphine dosage may be sufficient.<br />

• If acute pain is not relieved by non-opioid medications or an increase of buprenorphine,<br />

more aggressive pain management should be undertaken, including short-acting opioid pain<br />

relievers.<br />

• When patients on buprenorphine require o<strong>the</strong>r opioid treatment <strong>for</strong> pain, <strong>the</strong> following should<br />

be borne in mind:<br />

° Morphine should not be prescribed.<br />

° Buprenorphine should be discontinued while o<strong>the</strong>r opioid pain medication is being taken.<br />

° Higher doses of short-acting opioid pain medication may be needed to achieve analgesia<br />

until <strong>the</strong> buprenorphine clears <strong>the</strong> body, when <strong>the</strong>y should be decreased.<br />

° Buprenorphine should not be restarted until an appropriate period after <strong>the</strong> last dose of <strong>the</strong><br />

opioid analgesic, given its half-life.<br />

° Non-combination opioid analgesics are preferable to avoid toxicity <strong>and</strong> o<strong>the</strong>r side-effects,<br />

° Patients with chronic pain who do not respond to increased buprenorphine <strong>and</strong> continually<br />

<strong>and</strong> <strong>for</strong> easier dosage.<br />

require additional analgesia may need to be transferred to methadone treatment (131, 132).<br />

For fur<strong>the</strong>r in<strong>for</strong>mation on pain management, refer to Protocol 3, Palliative care <strong>for</strong> people living<br />

with <strong>HIV</strong>.<br />

26 For example, a woman on methadone who is in labour will require pain relief in exactly <strong>the</strong> same way as any o<strong>the</strong>r preg-<br />

nant woman.<br />

195

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!